| abstract |
There is provided a compound having the structure of formula (I) or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope or salt thereof, wherein X 1 、X 2 And R 1 As defined herein. Such compounds are useful as thyromimetic agents and have utility for the treatment of diseases such as neurodegenerative and fibrotic diseases. Pharmaceutical compositions containing such compounds, as well as their use and preparation are also provided. |